Glyx Therapeutics to Participate in the 6th Trinational HealthTech Days
October 2025 — Amiens, France
Glyx Therapeutics will take part in the 6th edition of the Trinational HealthTech Days, organized by Quest For Health, the health incubator of the Grand Est region. The event brings together health innovations, investors, and strategic partners across the tri-national ecosystem, and offers Glyx a direct opportunity to advance new investor relationships as it prepares its Seed round.
Why This Event Matters
The Trinational HealthTech Days is a key platform for connecting emerging health companies with the capital and partners needed to accelerate development. For Glyx Therapeutics, currently advancing a first-in-class, brain-penetrant tau therapy toward clinical proof-of-concept, the event supports two priorities: engaging with ecosystem stakeholders and welcoming new investors to its capital.
Event Details
The program is structured across two complementary days:
- November 13, 2025 — Basel (in-person): A full day of conferences and networking. The complete program is available here: https://lnkd.in/d64UEqCh
- November 14, 2025 — Online: A day of targeted business meetings connecting startups with investors and industrial partners.
The event is open to all health startups across Biotech, Medtech, and Digital Health, whether in the creation phase or already established.
What to Expect
Glyx Therapeutics looks forward to exchanging with players across the health ecosystem, inviting new investors to join its capital, and discovering the innovations shaping the future of healthcare. These interactions reinforce Glyx’s mission to develop differentiated therapeutic strategies against tauopathies and Alzheimer’s disease.
Connect With Us
Interested in meeting the Glyx Therapeutics team during the Trinational HealthTech Days?
Contact us to schedule a discussion
